Media coverage
4
Media coverage
Title Adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer Media name/outlet UChicago Medicine Country/Territory United States Date 1/09/23 URL https://www.uchicagomedicine.org/forefront/cancer-articles/adding-immune-modulator-to-targeted-therapy-does-not-improve-survival-in-difficult-to-treat-thyroid-cancer Persons Matthew Wilkerson Title Adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer Media name/outlet EurekAlert! Country/Territory United States Date 1/09/23 URL https://www.eurekalert.org/news-releases/1000346 Persons Matthew Wilkerson Title Adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer Media name/outlet Newswise Country/Territory United States Date 1/09/23 URL https://www.newswise.com/articles/adding-immune-modulator-to-targeted-therapy-does-not-improve-survival-in-difficult-to-treat-thyroid-cancer Persons Matthew Wilkerson Title Immune Modulator Fails to Boost Survival in Tough Thyroid Cancer Media name/outlet Mirage News Country/Territory Australia Date 1/09/23 URL https://www.miragenews.com/immune-modulator-fails-to-boost-survival-in-1076566/ Persons Matthew Wilkerson